Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Teprotumumab and Thyroid Eye Disease

Teprotumumab and Thyroid Eye Disease

FromExperts InSight


Teprotumumab and Thyroid Eye Disease

FromExperts InSight

ratings:
Length:
30 minutes
Released:
Dec 31, 2021
Format:
Podcast episode

Description

Drs. Alison Watson and Seanna Grob review recent data on teprotumumab, the only FDA-approved therapy for thyroid eye disease. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
Released:
Dec 31, 2021
Format:
Podcast episode

Titles in the series (67)

Practical, topical conversations with experts across the spectrum of ophthalmology. Subscribe for the latest information, evidence-based practice standards, and innovations in eye care, from the American Academy of Ophthalmology.